Immune dysregulation in myelodysplastic syndrome

by Chiharu Sugimori, Alan F. List, Pearlie K. Epling-Burnette
Published 2010-01-01

Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis

by Ambuj Kumar, Alan F. List, Iztok Hozo, Rami Komrokji, Benjamin Djulbegovic
Published 2010-02-01

Erythropoietin receptor signaling is membrane raft dependent.

by Kathy L McGraw, Gwenny M Fuhler, Joseph O Johnson, Justine A Clark, Gisela C Caceres, Lubomir Sokol, Alan F List
Published 2012-01-01

Lenalidomide induces lipid raft assembly to enhance erythropoietin receptor signaling in myelodysplastic syndrome progenitors.

by Kathy L McGraw, Ashley A Basiorka, Joseph O Johnson, Justine Clark, Gisela Caceres, Eric Padron, Ruth Heaton, Yukiyasu Ozawa, Sheng Wei, Lubomir Sokol, Alan F List
Published 2014-01-01

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care...

by Steven D. Gore, Pierre Fenaux, Valeria Santini, John M. Bennett, Lewis R. Silverman, John F. Seymour, Eva Hellström-Lindberg, Arlene S. Swern, Charles. L. Beach, Alan. F. List
Published 2013-07-01

Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia

by Kathy L. McGraw, Johnny Nguyen, Rami S. Komrokji, David Sallman, Najla H. Al Ali, Eric Padron, Jeffrey E. Lancet, Lynn C. Moscinski, Alan F. List, Ling Zhang
Published 2016-08-01

Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34+ cells from patients with del(5q) myelodysplastic syndrome

by Christopher P. Venner, Joanna Wegrzyn Woltosz, Thomas J. Nevill, H. Joachim Deeg, Gisela Caceres, Uwe Platzbecker, Bart L. Scott, Lubomir Sokol, Sandy Sung, Alan F. List, Aly Karsan
Published 2013-03-01

A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction

by Rami S. Komrokji, Adam W. Mailloux, Dung-Tsa Chen, Mikkael A. Sekeres, Ronald Paquette, William J. Fulp, Chiharu Sugimori, Jennifer Paleveda-Pena, Jaroslaw P. Maciejewski, Alan F. List, Pearlie K. Epling-Burnette
Published 2014-07-01

Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning

by David A. Sallman, Rafael Bejar, Guillermo Montalban-Bravo, Sandra E. Kurtin, Alan F. List, Guillermo Garcia-Manero, Stephen D. Nimer, Casey L. O'Connell, Dale Schaar, Janice Butchko, Tracey Iraca, Stephanie Searle
Published 2022-01-01

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

by Gregory A. Abel, Fabio Efficace, Rena J. Buckstein, Sara Tinsley, Joseph G. Jurcic, Yolanda Martins, David. P Steensma, Corey D. Watts, Azra Raza, Stephanie J. Lee, Alan F. List, Robert J. Klaassen
Published 2016-06-01

Dual pyroptotic biomarkers predict erythroid response in lower-risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin

by Chen Wang, Kathy L. McGraw, Amy F. McLemore, Rami Komrokji, Ashley A. Basiorka, Najla Al Ali, Jeffrey E. Lancet, Eric Padron, Olivier Kosmider, Michaela Fontenay, Pierre Fenaux, Alan F. List, David A. Sallman
Published 2021-07-01

The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia.

by Era L Pogosova-Agadjanyan, Kenneth J Kopecky, Fabiana Ostronoff, Frederick R Appelbaum, John Godwin, Hana Lee, Alan F List, Jennifer J May, Vivian G Oehler, Steve Petersdorf, Galina L Pogosov, Jerald P Radich, Cheryl L Willman, Soheil Meshinchi, Derek L Stirewalt
Published 2013-01-01

Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia

by Sarah Abu Kar, Anna Jankowska, Hideki Makishima, Valeria Visconte, Andres Jerez, Yuka Sugimoto, Hideki Muramatsu, Fabiola Traina, Manuel Afable, Kathryn Guinta, Ramon V. Tiu, Bartlomiej Przychodzen, Hirotoshi Sakaguchi, Seiji Kojima, Mikkael A. Sekeres, Alan F. List, Michael A. McDevitt, Jaroslaw P. Maciejewski
Published 2013-01-01

Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes

by Amy F. McLemore, Hsin-An Hou, Benjamin S. Meyer, Nghi B. Lam, Grace A. Ward, Amy L. Aldrich, Matthew A. Rodrigues, Alexis Vedder, Ling Zhang, Eric Padron, Nicole D. Vincelette, David A. Sallman, Omar Abdel-Wahab, Alan F. List, Kathy L. McGraw
Published 2022-08-01

The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

by Aziz Nazha, Rami S. Komrokji, Guillermo Garcia-Manero, John Barnard, Gail J. Roboz, David P. Steensma, Amy E. DeZern, Katrina Zell, Cassie Zimmerman, Najla Al Ali, Elias Jabbour, Molly D. Greenberg, Hagop M. Kantarjian, Jaroslaw P. Maciejewski, Alan F. List, Mikkael A. Sekeres
Published 2016-06-01

An International MDS/MPN Working Group’s perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative ne...

by Tariq I. Mughal, Nicholas C.P. Cross, Eric Padron, Ramon V. Tiu, Michael Savona, Luca Malcovati, Raoul Tibes, Rami S. Komrokji, Jean-Jacques Kiladjian, Guillermo Garcia-Manero, Attilio Orazi, Ruben Mesa, Jaroslaw P. Maciejewski, Pierre Fenaux, Raphael Itzykson, Ghulam Mufti, Eric Solary, Alan F. List
Published 2015-09-01

Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)

by Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, Odile Beyne-Rauzy, Moshe Mittelman, Petra Muus, Stephen D. Nimer, Eva Hellström-Lindberg, Bayard L. Powell, Agnes Guerci-Bresler, Mikkael A. Sekeres, H. Joachim Deeg, Consuelo del Cañizo, Peter L. Greenberg, Jamile M. Shammo, Barry Skikne, Xujie Yu, Alan F. List
Published 2017-06-01

Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia

by Catherine C. Coombs, David A. Sallman, Sean M. Devlin, Shweta Dixit, Abhinita Mohanty, Kristina Knapp, Najla H. Al Ali, Jeffrey E. Lancet, Alan F. List, Rami S. Komrokji, Eric Padron, Maria E. Arcila, Virginia M. Klimek, Marcel R. M. van den Brink, Martin S. Tallman, Ross L. Levine, Raajit K. Rampal, Franck Rapaport
Published 2016-11-01

Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes

by Grace A. Ward, Robert P. Dalton, Benjamin S. Meyer, Amy F. McLemore, Amy L. Aldrich, Nghi B. Lam, Alexis H. Onimus, Nicole D. Vincelette, Thu Le Trinh, Xianghong Chen, Alexandra R. Calescibetta, Sean M. Christiansen, Hsin-An Hou, Joseph O. Johnson, Kenneth L. Wright, Eric Padron, Erika A. Eksioglu, Alan F. List
Published 2023-02-01

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report

by Era L. Pogosova-Agadjanyan, Anna Moseley, Megan Othus, Frederick R. Appelbaum, Thomas R. Chauncey, I-Ming L. Chen, Harry P. Erba, John E. Godwin, Isaac C. Jenkins, Min Fang, Mike Huynh, Kenneth J. Kopecky, Alan F. List, Jasmine Naru, Jerald P. Radich, Emily Stevens, Brooke E. Willborg, Cheryl L. Willman, Brent L. Wood, Qing Zhang, Soheil Meshinchi, Derek L. Stirewalt
Published 2020-08-01